Papers: 10.1002/advs.201900782

https://doi.org/10.1002/advs.201900782

Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma

Cited by: 43
Author(s): Kai Huang, Xing Liu, Yansheng Li, Qixue Wang, Junhu Zhou, Yunfei Wang, Feng Dong, Chao Yang, Zimin Sun, Chuan Fang, Chaoyong Liu, Yanli Tan, Xudong Wu, Tao Jiang, Chunsheng Kang
Published: about 7 years ago

Software Mentions 1